Hans Bigalke

Botulinum A Toxin Therapy: Neutralizing and Nonneutralizing Antibodies—Therapeutic Consequences

Hilke Göschel, Kai Wohlfarth, Jürgen Frevert et al. · Experimental Neurology · 1997 · 316 citations

Toxinology, Immunology, Therapeutic Vaccine +4

The synaptic vesicle protein 2C mediates the uptake of botulinum neurotoxin A into phrenic nerves

Stefan Mahrhold, Andreas Rummel, Hans Bigalke et al. · FEBS Letters · 2006 · 315 citations

Synaptotagmins I and II Act as Nerve Cell Receptors for Botulinum Neurotoxin G

Andreas Rummel, Tino Karnath, Tina Henke et al. · Journal of Biological Chemistry · 2004 · 237 citations · Full text

The H_CC‐domain of botulinum neurotoxins A and B exhibits a singular ganglioside binding site displaying serotype specific carbohydrate interaction

Andreas Rummel, Stefan Mahrhold, Hans Bigalke et al. · Molecular Microbiology · 2003 · 220 citations · Full text

Full-length Neurotoxins, Biochemistry, Natural Sciences +14

Identification of the protein receptor binding site of botulinum neurotoxins B and G proves the double-receptor concept

Andreas Rummel, Timo Eichner, Tanja Weil et al. · Proceedings of the National Academy of Sciences · 2006 · 177 citations · Full text

Neurotransmitter, Immunology, Molecular Biology +19